Intragenic CAMTA1 deletions are associated with a spectrum of neurobehavioral phenotypes.

Related Articles

Intragenic CAMTA1 deletions are associated with a spectrum of neurobehavioral phenotypes.

Clin Genet. 2015 May;87(5):478-82

Authors: Shinawi M, Coorg R, Shimony JS, Grange DK, Al-Kateb H

Abstract
Intragenic copy number variations involving the CAMTA1 (calmodulin-binding transcription activator 1) gene have recently been reported in four unrelated families with intellectual disability (ID), ataxia, behavioral- and cerebellar-abnormalities. We report a detailed phenotypic and molecular characterization of three individuals with novel intragenic CAMTA1 deletions from two unrelated families and compare the findings to those of previously reported patientse proteins perform in the central nervous system. Studies on animal, pharmacological and molecular genetic models yield evidence that relates neurotrophins with the disorder. This work reviews the results from the studies conducted to date on ADHD and neurotrophic factors, especially brain-derived neurotrophic factor (BDNF). Thus, although pharmacological studies suggest that the response to atomoxetine in adults with ADHD is not directly mediated by the effect on the BDNF, reductions in BDNF levels in the plasma of adult patients with ADHD have been reported. Further studies with broader samples and greater control of environmental factors that can regulate neurotrophin expression, such as diet, physical exercise and situations of social risk, are needed to be able to determine the role they play in the aetiology of ADHD.

PMID: 25252662 [PubMed – indexed for MEDLINE]

via http://www.ncbi.nlm.nih.gov/pubmed/24738973?dopt=Abstract